Antitumor effects of polysorbate-80 coated gemcitabine polybutylcyanoacrylate nanoparticles in vitro and its pharmacodynamics in vivo on C6 glioma cells of a brain tumor model
Authors:
- Chun-Xia WangCWChun-Xia Wang
- Le-Song HuangLHLe-Song Huang
- Lian-Bing HouLHLian-Bing Hou
- Liang JiangLJLiang Jiang
- Zhi-Ting YanZYZhi-Ting Yan
- Yu-Lun WangYWYu-Lun Wang
- Zhi-Liang ChenZCZhi-Liang Chen
- 1 March 2009
- journal article
- Published by Elsevier in Brain Research
- Vol. 1261, 91-99
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Pt/TiO2 brain biocompatible nanoparticles: GBM treatment using the C6 model in Wistar ratsActa Biomaterialia, 2008
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Nanomedicine for implants: A review of studies and necessary experimental toolsBiomaterials, 2007
- Interleukin-13 receptor–targeted nanovesicles are a potential therapy for glioblastoma multiformeMolecular Cancer Therapeutics, 2006
- In vitro degradation of insulin-loaded poly (n-butylcyanoacrylate) nanoparticlesBiomaterials, 2004
- Small-scale systems for in vivo drug deliveryNature Biotechnology, 2003
- Poly(butylcyanoacrylate) nanoparticles for topical delivery of 5-fluorouracilInternational Journal of Pharmaceutics, 2003
- Nanoparticles in cancer therapy and diagnosisAdvanced Drug Delivery Reviews, 2002
- Apolipoprotein-mediated Transport of Nanoparticle-bound Drugs Across the Blood-Brain BarrierJournal of Drug Targeting, 2002
- Stealth Me. PEG‐PLA Nanoparticles Avoid Uptake by the Mononuclear Phagocytes SystemJournal of Pharmaceutical Sciences, 1995